NEOGEN CORP(NEOG)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,890 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
NEOG Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for NEOGEN CORP (NEOG), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NEOG at 44.9/100 on a 32-signal composite quality model, placing it at rank #1,890 of 2,962 stocks — the bottom half of the AI-ranked universe. NEOG scores in the top quartile across earnings quality (97.4). Areas of concern include revenue growth (16.9) and institutional flow (31.5), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), NEOGEN CORP reports quarterly revenue of $225.3M, net income of $-11.3M, free cash flow of $26.2M. Top institutional holders of NEOG by reported 13-F value include BlackRock, Neuberger Berman Group, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. NEOG trades on the Nasdaq exchange and files with the SEC under CIK 711377. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NEOG daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEOGEN CORP directly from SEC EDGAR. NEOGEN CORP's 13F Pro composite quality score has ranged between 26 and 59 since 2021, currently 44.9 — a declining long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$225.3M
Net Income
Q2 2026
$-11.3M
Free Cash Flow
Q2 2026
$26.2M
ROIC
Q2 2026
0.3%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-2.7% YoYNet Income
+99.3% YoYOperating Income
+98.0% YoYEPS (Diluted)
+99.2% YoYTotal Assets
-2.8% YoYTotal Debt
-11.3% YoYOp. Cash Flow
+43.0% YoYFree Cash Flow
+168.8% YoY| Metric | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $870.4M -2.7% | $894.7M -3.2% | $924.2M +12.4% | $822.4M +56.0% | $527.2M +12.5% | $468.5M |
| Net Income | $-7.9M +99.3% | $-1.09B -11517.0% | $-9.4M +58.9% | $-22.9M -147.3% | $48.3M -20.7% | $60.9M |
| Operating Income | $-21.6M +98.0% | $-1.06B -1910.6% | $58.6M +56.2% | $37.5M -36.0% | $58.6M -21.0% | $74.2M |
| EPS (Diluted) | $-0.04 +99.2% | $-5.03 -12475.0% | $-0.04 +66.7% | $-0.12 -153.3% | $0.23 -21.1% | $0.28 |
| Total Assets | $3.35B -2.8% | $3.44B -24.3% | $4.55B -0.1% | $4.55B +358.7% | $992.9M +7.9% | $920.2M |
| Total Debt | $1.59B -11.3% | $1.80B +0.3% | $1.79B +0.3% | $1.79B | $0.00 | — |
| Operating Cash Flow | $83.2M +43.0% | $58.2M +64.9% | $35.3M -14.0% | $41.0M -39.7% | $68.0M -16.1% | $81.1M |
| Free Cash Flow | $31.9M +168.8% | $-46.4M +39.0% | $-76.1M -207.7% | $-24.7M -156.7% | $43.6M -19.8% | $54.4M |
Get alerted when NEOG's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for NEOGEN CORP including:
Top Institutional Holders of NEOG
BlackRock, Inc.
$300.5M33,431,015 shNeuberger Berman Group LLC
$149.0M16,570,795 shVANGUARD PORTFOLIO MANAGEMENT LLC
$117.2M13,038,732 shDIMENSIONAL FUND ADVISORS LP
$88.4M9,828,174 shVANGUARD CAPITAL MANAGEMENT LLC
$86.8M9,655,248 shSG Americas Securities, LLC
$84.1M9,352,065 shT. Rowe Price Investment Management, Inc.
$83.9M9,333,261 shING GROEP NV
$81.8M9,102,300 shSTATE STREET CORP
$80.4M8,946,377 shGates Capital Management, Inc.
$78.6M8,742,274 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $300.5M | 33,431,015 |
| Neuberger Berman Group LLC | $149.0M | 16,570,795 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.2M | 13,038,732 |
| DIMENSIONAL FUND ADVISORS LP | $88.4M | 9,828,174 |
| VANGUARD CAPITAL MANAGEMENT LLC | $86.8M | 9,655,248 |
| SG Americas Securities, LLC | $84.1M | 9,352,065 |
| T. Rowe Price Investment Management, Inc. | $83.9M | 9,333,261 |
| ING GROEP NV | $81.8M | 9,102,300 |
| STATE STREET CORP | $80.4M | 8,946,377 |
| Gates Capital Management, Inc. | $78.6M | 8,742,274 |
Companies Similar to NEOG
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
INTEGRA LIFESCIENCES HOLDINGS CORP
Orthofix Medical Inc.
Envista Holdings Corp
Fortrea Holdings Inc.
Integer Holdings Corp
DENTSPLY SIRONA Inc.
AVANOS MEDICAL, INC.
Sarepta Therapeutics, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put NEOG on your watchlist
Track score changes the day NEOGEN CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NEOG a good stock to buy?
13F Pro's AI-powered analysis of NEOGEN CORP (NEOG) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NEOG are available on the NEOG stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. NEOG is classified as a mid company.
Which hedge funds own NEOG?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NEOG. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NEOGEN CORP's investment landscape.